Cargando…

Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in Apc(Min/)(+) Mice

SIMPLE SUMMARY: Splicing factor 1 (SF1) is a widely expressed alternative splicing factor that is able to process each piece of genetic information to generate different types of messenger RNAs (or alternate messages). The alternate messages can generate proteins with slightly different structure or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godavarthi, Jyotsna D., Polk, Shahrazad, Nunez, Lisa, Shivachar, Amruthesh, Glenn Griesinger, Nancy L., Matin, Angabin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697247/ https://www.ncbi.nlm.nih.gov/pubmed/33202710 http://dx.doi.org/10.3390/biology9110398

Ejemplares similares

The Role of DND1 in Cancers
por: Zhang, Yun, et al.
Publicado: (2021)

Curcumin suppresses intestinal polyps in APC Min mice fed a high fat diet
por: Pettan-Brewer, Christina, et al.
Publicado: (2011)

Exercise effects on polyp burden and immune markers in the Apc(Min)(/+) mouse model of intestinal tumorigenesis
por: McCLELLAN, JAMIE L., et al.
Publicado: (2014)

Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc(Min/+) mutation
por: Dorman, Alexandra, et al.
Publicado: (2016)

Berberine Inhibits Intestinal Polyps Growth in Apc (min/+) Mice via Regulation of Macrophage Polarization
por: Piao, Meiyu, et al.
Publicado: (2016)

Erratum to: Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc Min/+ mutation
por: Dorman, Alexandra, et al.
Publicado: (2016)

In silico analysis of DND1 and its co-expressed genes in human cancers
por: Zhang, Yun, et al.
Publicado: (2022)

Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation
por: Barone, Michele, et al.
Publicado: (2015)

HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apc(min/+) mice
por: Tanaka, Hiromitsu, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach
por: Ranganna, Kasturi, et al.
Publicado: (2020)

Systemic TM4SF5 overexpression in Apc(Min/+) mice promotes hepatic portal hypertension associated with fibrosis
por: Lee, Joohyeong, et al.
Publicado: (2022)

Sesamol suppresses cyclooxygenase-2 transcriptional activity in colon cancer cells and modifies intestinal polyp development in Apc(Min/+) mice
por: Shimizu, Satomi, et al.
Publicado: (2014)

Malic Enzyme 1 (ME1) is pro-oncogenic in Apc(Min/+) mice
por: Fernandes, Lorenzo M., et al.
Publicado: (2018)

ERK activation drives intestinal tumorigenesis in Apc(min/)(+) mice
por: Lee, Sung Hee, et al.
Publicado: (2010)

Metabolomics of Apc( Min/+ ) mice genetically susceptible to intestinal cancer
por: Dazard, Jean-Eudes J, et al.
Publicado: (2014)

OGA heterozygosity suppresses intestinal tumorigenesis in Apc(min/+) mice
por: Yang, Y R, et al.
Publicado: (2014)

Intestinal Peyer’s patches prevent tumorigenesis in Apc(Min/+) mice
por: Fujimoto, Kyoko, et al.
Publicado: (2015)

Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling
por: Zhang, Junfang, et al.
Publicado: (2013)

Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc(Min/+) mice
por: Huang, Guoxin, et al.
Publicado: (2017)

Genetic mapping of novel modifiers for Apc(Min) induced intestinal polyps’ development using the genetic architecture power of the collaborative cross mice
por: Dorman, Alexandra, et al.
Publicado: (2021)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

Elevated Incidence of Polyp Formation in APC(Min/+)Msh2(−/−) Mice Is Independent of Nitric Oxide-Induced DNA Mutations
por: Belcheva, Antoaneta, et al.
Publicado: (2013)

Chemopreventive effects of berberine on intestinal tumor development in Apc(min/+) mice
por: Cao, Hailong, et al.
Publicado: (2013)

Dietary Uridine Decreases Tumorigenesis in the Apc(Min/+) Model of Intestinal Cancer
por: Field, Martha S, et al.
Publicado: (2018)

Increased variability in Apc(Min)/+ intestinal tissue can be measured with microultrasound
por: Fatehullah, A., et al.
Publicado: (2016)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APC(Min/+) mice
por: Li, Ye, et al.
Publicado: (2016)

Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of Apc(Min/+) mice
por: Zhong, Zhenyu, et al.
Publicado: (2017)

Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice
por: Ishigamori, Rikako, et al.
Publicado: (2017)

Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc(Min/+) mice
por: He, Zhengxiang, et al.
Publicado: (2017)

Extrinsic intestinal denervation modulates tumor development in the small intestine of Apc(Min/+) mice
por: Liu, Verena, et al.
Publicado: (2015)

Lactonic Sophorolipids Increase Tumor Burden in Apc(min+/-) Mice
por: Callaghan, Breedge, et al.
Publicado: (2016)

Platelet status in cancer cachexia progression in Apc(Min/+) mice
por: Cunningham, Patrice, et al.
Publicado: (2023)

Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC(+/min) Mouse Model
por: Leko, Vid, et al.
Publicado: (2013)

LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden
por: Guillen-Ahlers, Hector, et al.
Publicado: (2010)

Intestinal tumor suppression in Apc(Min/+) mice by prostaglandin D(2) receptor PTGDR
por: Tippin, Brigette L, et al.
Publicado: (2014)

The effect of exercise on IL-6-induced cachexia in the Apc(Min/+) mouse
por: Puppa, Melissa J., et al.
Publicado: (2011)

Therapeutic utility of aspirin in the Apc(Min/+) murine model of colon carcinogenesis
por: Reuter, Brian K, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ev73vqg6kg64q6trsrqf0a9b32